Abstract P1-13-06: Does histological subtype play a role in treatment decision-making for hormone receptor positive metastatic breast cancer? A study of the Southeast Netherlands b... by Lobbezoo, DJA, Truin, W, Voogd, AC, Roumen, RMH, Vreudgenhil, G, Dercksen, MW, van den Berkmortel, F, Smilde, TJ, van de Wouw, AJ, van Kampen, RJW, van Riel, JMGH, Peters, NAJB, Peer, PGM, Tjan-Heijnen, VCG

Get full text

Abstract P3-13-11: Unexpected large treatment and outcome variations in metastatic breast cancer: Results of a hormone receptor positive cohort study in the Netherlands by Tjan-Heijnen, VCG, Lobbezoo, DJA, van Kampen, RJW, Voogd, AC, Dercksen, M, van den Berkmortel, F, Smilde, TJ, van de Wouw, AJ, Peters, FPJ, van Riel, JMGH, Peters, NAJB, de Boer, M, Peer, PGM

Get full text

Abstract P6-07-32: Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2 positive subtype is associated with the most favorable outcome by Tjan-Heijnen, VCG, Lobbezoo, DJA, van Kampen, RJW, Voogd, AC, Dercksen, MW, van den Berkmortel, F, Smilde, TJ, van de Wouw, AJ, Peters, FPJ, van Riel, JMGH, Peters, NAJB, Borm, GF

Get full text

Gemcitabine–radiotherapy in patients with locally advanced pancreatic cancer by de Lange, S.M., van Groeningen, C.J., Meijer, O.W.M., Cuesta, M.A., Langendijk, J.A., van Riel, J.M.G.H., Pinedo, H.M., Peters, G.J., Meijer, S., Slotman, B.J., Giaccone, G.

Get full text

Continuous administration of irinotecan by hepatic arterial infusion: A Phase I and pharmacokinetic study by VAN RIEL, Johanna M. G. H, VAN GROENINGEN, Cees J, KEDDE, Mark A, GALL, Helen, LEISINK, Johanna M. A, GRUIA, Gabriella, PINEDO, Herbert M, VAN DER VIJGH, Wim J. F, GIACCONE, Giuseppe

Get full text

Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer by POSTMA, T. J, HOEKMAN, K, VAN RIEL, J. M. G. H, HEIMANS, J. J, VERMORKEN, J. B

Get full text